Human CDH17 / Cadherin-17, Fc Tag plays a crucial role in cancer research, particularly for gastrointestinal cancers such as colorectal, hepatocellular (liver), and gastric cancers. CDH17 is often highly expressed in these cancer cells, serving as a biomarker and potential target for diagnostic and therapeutic development.

In practical applications, this Fc-tagged protein is used as a control or antigen in ELISA assays and other immunoassay techniques to measure antibody levels and evaluate immune responses against CDH17.

Additionally, it facilitates studies on ligand and protein binding interactions to elucidate cancer cell adhesion, metastasis mechanisms, and tumor progression. This contributes to the development of targeted therapies and therapeutic antibodies with high specificity for cancer cells, minimizing damage to normal cells. The Fc tag enhances detection and purification, making it invaluable in research and biotech applications.